Awwad, Mohamed H. S.
Mahmoud, Abdelrahman
Bruns, Heiko
Echchannaoui, Hakim
Kriegsmann, Katharina
Lutz, Raphael
Raab, Marc S.
Bertsch, Uta
Munder, Markus
Jauch, Anna
Weisel, Katja
Maier, Bettina
Weinhold, Niels
Salwender, Hans Jürgen
Eckstein, Volker
Hänel, Mathias
Fenk, Roland
Dürig, Jan
Brors, Benedikt http://orcid.org/0000-0001-5940-3101
Benner, Axel
Müller-Tidow, Carsten http://orcid.org/0000-0002-7166-5232
Goldschmidt, Hartmut http://orcid.org/0000-0003-0961-0035
Hundemer, Michael http://orcid.org/0000-0002-5596-2405
Funding for this research was provided by:
Bristol-Myers Squibb
Celgene
Article History
Received: 13 October 2020
Revised: 13 January 2021
Accepted: 28 January 2021
First Online: 17 February 2021
Compliance with ethical standards
:
: MHSA<b>:</b> Research funding from BMS and Celgene. AM: none. HB: Research grant by Morphosys and Celgene Corporation. HE: Research funding from BMS. KK: Research funding from BMS, Celgene, Sanofi and Novartis. RL: None. MSR: Research Support (Institutions): Amgen, Novartis. Advisory Boards (Institutions): Amgen, BMS, Celgene, Janssen, Sanofi, Takeda. UB: none. MM: Consultancy: Janssen, Celgene, Takeda, GSK, Sanofi, BMS. AJ: None. KW: Received honoraria and is advisory board member of Amgen, BMS, Celgene, Karyopharm, GSK, Sanofi, Takeda, Janssen and received research funding (to the institution) from Amgen, Celgene, Sanofi and Janssen. BM: none. NW: none. HJS: Honoraria from AbbVie, Janssen Cilag, Celgene, Takeda, Sanofi, Bristol Myers Squibb, Amgen, Oncopeptides, Glaxo Smith Kline; travel, accommodations, expenses from Janssen Cilag, Celgene, Takeda, Sanofi, Bristol Myers Squibb, Amgen. VK: None. MHä: Honorare/Advisory Boards von Amgen, Takeda, Celgene, Sanofi, Novartis. RF: Honoraria and Travelgrants Celgene from BMS, Amgen, Takeda. JD: none. BB: none. AB: none. CMT: none. HG: Grants and/or provision of Investigational Medicinal Product (IMP*): Amgen, BMS, Celgene, Chugai, Dietmar-Hopp-Stiftung, Janssen, John Hopkins University, Sanofi. Research Support (Institutions): Amgen, BMS, Celgene, Chugai, Janssen, Molecular Partners, MSD, Sanofi, Mundipharma, Takeda, Novartis Advisory Boards (Institutions): Adaptive Biotechnology, Amgen, BMS, Celgene, Janssen, Sanofi, Takeda Honoraria (Speakers Bureaus): ArtTempi, BMS, Celgene, Chugai, Janssen, Novartis, Sanofi. MH: Research funding from BMS, Celgene, Sanofi, and Novartis.